Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Use of Additional Doses of 2024–2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024

MMWR Morbidity and Mortality Weekly Report(2024)10.15585/mmwr.mm7349a2Source: DataRank Database

Use of Additional Doses of 2024–2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 is a research paper published in MMWR Morbidity and Mortality Weekly Report (2024). On theSindex it has a DataRank of 0. It has been cited 28 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access28 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 8.74)OA: goldTopics (19)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Monica Godfrey,Ruth Link‐Gelles ORCID,Danielle Moulia,Christopher A. Taylor ORCID,Georgina Peacock

Live enrichment

PubMed:21097893 PMC:PMC11637417 OpenAlex:https://openalex.org/W4405315056

FWCI

8.74

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: public-domain

journalhttps://www.cdc.gov/mmwr/volumes/73/wr/pdfs/mm7349a2-H.pdf

GOLDhttps://doi.org/10.15585/mmwr.mm7349a2

publisherhttps://www.cdc.gov/mmwr/volumes/73/wr/pdfs/mm7349a2-H.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11637417

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11637417/pdf/mm7349a2.pdf

Fields of Study

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyHepatitis B Virus StudiesMedicine

Keywords

Coronavirus disease 2019 (COVID-19)Advisory committeeMedicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunizationFamily medicineEnvironmental healthVirologyOutbreakImmunologyPolitical scienceDiseaseInternal medicineInfectious disease (medical specialty)

Sustainable Development Goals

SDG 0: Good health and well-being